Huang Zhichao, Deng Fei, Deng Zebin, Wang Yinhuai, Cheng Xu
Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
BMC Nephrol. 2025 Jul 1;26(1):311. doi: 10.1186/s12882-025-04232-x.
BACKGROUND: Obstructive nephropathy (ON) is caused by obstruction of urine flow, featured with progressive renal dysfunction and progressing into chronic kidney disease. There is still controversy whether to remove the kidney or simply relieve obstruction in patients with late diagnosis. Reliable biomarker is needed for predicting renal function reversibility in ON patients. As the frontier in non-coding RNA research, circRNA is involved in the pathological progress of ON, however, the correlation between hsa_circ_0012138 expression and renal function reversibility remains unknown. METHODS: RT-qPCR and RNA-fluorescence in situ hybridization (RNA-FISH) to identify hsa_circ_0012138; Bioinformatics analysis: Gene Set Enrichment Analysis (GSEA); Clinical data analysis: the receiver operating characteristic (ROC) curves. RESULTS: In this study we identified hsa_circ_0012138 expression in the kidney tissue by RT-qPCR. By GSEA enrichment, we speculated that it may regulate the expression of multiple target genes related to renal fibrosis through ceRNA mechanism. We further detected its expression in urine of ON patients with different stage. Combined with the other clinical variables, statistical analysis found that, compared with NAGL, hsa_circ_0012138 has good specificity and sensitivity in prediction the renal function reversibility after kidney-sparing surgery in ON patients, and is expected to be used as a prognostic marker to guide surgical decision-making.
背景:梗阻性肾病(ON)由尿流梗阻引起,以进行性肾功能障碍为特征,并可进展为慢性肾脏病。对于晚期诊断的患者,是切除肾脏还是单纯解除梗阻仍存在争议。需要可靠的生物标志物来预测ON患者的肾功能可逆性。作为非编码RNA研究的前沿领域,环状RNA(circRNA)参与了ON的病理进程,然而,hsa_circ_0012138的表达与肾功能可逆性之间的相关性仍不清楚。 方法:采用逆转录定量聚合酶链反应(RT-qPCR)和RNA荧光原位杂交(RNA-FISH)鉴定hsa_circ_0012138;生物信息学分析:基因集富集分析(GSEA);临床数据分析:绘制受试者工作特征(ROC)曲线。 结果:在本研究中,我们通过RT-qPCR鉴定了hsa_circ_0012138在肾组织中的表达。通过GSEA富集分析,我们推测它可能通过竞争性内源RNA(ceRNA)机制调节多个与肾纤维化相关的靶基因的表达。我们进一步检测了其在不同分期ON患者尿液中的表达。结合其他临床变量进行统计分析发现,与N-乙酰-β-D-氨基葡萄糖苷酶(NAGL)相比,hsa_circ_0012138在预测ON患者保肾手术后肾功能可逆性方面具有良好的特异性和敏感性,有望作为一种预后标志物来指导手术决策。
Cochrane Database Syst Rev. 2022-5-20
Arch Ital Urol Androl. 2025-6-30
Front Pharmacol. 2025-6-13
Health Technol Assess. 2006-9
Clin Orthop Relat Res. 2024-9-1
Cochrane Database Syst Rev. 2022-3-2
Int J Mol Sci. 2020-7-31
Front Genet. 2020-6-30
Front Cell Dev Biol. 2020-6-16
Front Pharmacol. 2019-10-8
Mol Cancer. 2019-7-5
J Cell Mol Med. 2019-6-18
J Histochem Cytochem. 2019-5-22